The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InQT Imaging Holdings, Inc. (Nasdaq: QTI) has announced that it received official regulatory clearance from the UAE’s Emirates Drug Establishment (EDE) for its innovative breast imaging technology. This approval allows the company to import and utilize its Breast Acoustic CT scanner as a certified medical device within the United Arab Emirates. The system is notable for being a radiation-free imaging solution, offering a safer alternative for diagnostic procedures. This milestone marks a significant step in the company's international expansion strategy, positioning the UAE as a strategic gateway to the Middle Eastern market. By securing this clearance, QT Imaging aims to commercialize its advanced medical technology globally and drive future revenue growth. The development underscores the company's commitment to expanding its clinical footprint and providing advanced healthcare solutions on an international scale.